Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen
Astrana Health (NASDAQ:ASTH-Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Sunday. GetAstrana Healthalerts: Several. . .
Astrana Health (NASDAQ:ASTH-Get Free Report)was downgraded by research analysts atWall Street Zenfrom a "buy" rating to a "hold" rating in a report released on Sunday. GetAstrana Healthalerts:Several other equities research analysts also recently weighed in on the stock. Robert W. Baird set a $45. 00 target price on shares of Astrana Health in a research note on Friday, May 8th. Needham & Company LLC boosted their price target on Astrana Health from $30. 00 to $41. 00 and gave the company a "buy" rating in a research report on Friday, May 8th. TD Cowen upped their price objective on Astrana Health from $45. 00 to $50. 00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. BTIG Research upped their price objective on Astrana Health from $50. 00 to $65. 00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Finally, Truist Financial increased their price objective on Astrana Health from $47. 00 to $55. 00 and gave the stock a "buy" rating in a research report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat. com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $49. 43. Check Out Our Latest Stock Report on Astrana HealthAstrana Health Trading Up 8. 0%Shares ofAstrana Health stockopened at $40. 81 on Friday. The company has a market cap of $2. 27 billion, a P/E ratio of 49. 77 and a beta of 0. 87. The firm has a 50-day simple moving average of $41. 34 and a two-hundred day simple moving average of $32. 83. The company has a debt-to-equity ratio of 1. 05, a quick ratio of 1. 35 and a current ratio of 1. 23. Astrana Health has a fifty-two week low of $18. 08 and a fifty-two week high of $51. 60. Institutional Trading of Astrana HealthSeveral hedge funds have recently made changes to their positions in ASTH. Great Lakes Advisors LLC acquired a new position in shares of Astrana Health during the second quarter worth about $832,000. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in Astrana Health in the second quarter valued at about $22,088,000. Bank of New York Mellon Corp acquired a new stake in Astrana Health in the second quarter valued at about $10,902,000. Bank of America Corp DE boosted its holdings in Astrana Health by 13. 3% in the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company's stock valued at $14,092,000 after purchasing an additional 67,628 shares in the last quarter. Finally, Edgestream Partners L. P. boosted its holdings in Astrana Health by 68. 3% in the 1st quarter. Edgestream Partners L. P. now owns 27,616 shares of the company's stock valued at $677,000 after purchasing an additional 11,209 shares in the last quarter. Institutional investors and hedge funds own 52. 77% of the company's stock. Astrana Health Company Profile(Get Free Report)Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Read MoreFive stocks we like better than Astrana HealthIs Best Buy the AI Winner Hiding in the Electronics Aisle?Applied Materials Beat Everything but Wall Street’s Expectations for MarginsBack From Orbit, Intuitive Machines' Share Price Enters the Buy ZoneTexas Roadhouse and Brinker International Have the Recipe Rivals Are MissingThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Astrana Health Right Now?Before you consider Astrana Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Astrana Health wasn't on the list. While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereEnter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report